Vivian P Bykerk

Summary

Affiliation: Hospital for Special Surgery
Country: USA

Publications

  1. doi request reprint Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice
    Vivian P Bykerk
    Inflammatory Arthritis Center, Hospital for Special Surgery, 535 East 70th Street, New York, NY, 10021, USA
    Clin Rheumatol 34:563-71. 2015
  2. ncbi request reprint Achieving remission in clinical practice: lessons from clinical trial data
    Vivian P Bykerk
    Hospital for Special Surgery, New York City, USA
    Clin Exp Rheumatol 31:621-32. 2013
  3. doi request reprint Treatment strategies for early rheumatoid arthritis
    Vivian P Bykerk
    1st Department of Medicine, Hospital for Special Surgery, Weill Cornell Medical College, New York, New York, USA
    Curr Opin Rheumatol 25:375-83. 2013
  4. pmc Tocilizumab in patients with active rheumatoid arthritis and inadequate responses to DMARDs and/or TNF inhibitors: a large, open-label study close to clinical practice
    Vivian P Bykerk
    Inflammatory Arthritis Center, Hospital for Special Surgery, New York, NY 10021, USA
    Ann Rheum Dis 71:1950-4. 2012
  5. doi request reprint The new ACR/EULAR remission criteria: rationale for developing new criteria for remission
    Vivian P Bykerk
    Inflammatory Arthritis Center, Hospital for Special Surgery, 535 East 70th Street, 6th Floor, New York, NY 10021, USA
    Rheumatology (Oxford) 51:vi16-20. 2012
  6. doi request reprint The new ACR/EULAR classification criteria for RA: how are the new criteria performing in the clinic?
    Vivian P Bykerk
    Inflammatory Arthritis Center, Hospital for Special Surgery, 535 East 70th Street, 6th Floor, New York, NY 10021, USA
    Rheumatology (Oxford) 51:vi10-5. 2012
  7. doi request reprint Effect of age at menopause on disease presentation in early rheumatoid arthritis: results from the canadian early arthritis cohort
    Lauren E Wong
    Hospital for Special Surgery Weill Cornell Medical College, New York, New York
    Arthritis Care Res (Hoboken) 67:616-23. 2015
  8. doi request reprint Does socioeconomic status affect outcomes in early inflammatory arthritis? Data from a canadian multisite suspected rheumatoid arthritis inception cohort
    Grace Yang
    From the Schulich School of Medicine and Dentistry, Department of Internal Medicine, University of Western Ontario, London, Ontario, Canada Rheumatology, Hospital for Special Surgery, Cornell University, New York, New York, USA Rheumatology Division, Universite de Sherbrooke, Sherbrooke, Quebec Arthritis Centre, University of Manitoba, Winnipeg, Manitoba Southlake Regional Health Centre, Newmarket, Ontario Rheumatic Disease Unit, Institut de Rhumatologie, Montreal, Quebec Rheumatology, Mount Sinai Hospital, University of Toronto, Toronto Rheumatology, St Joseph s Health Care, London, Ontario, Canada G Yang, MD, Schulich School of Medicine and Dentistry, Department of Internal Medicine, University of Western Ontario V P Bykerk, MD, FRCPC, Rheumatology, Hospital for Special Surgery, Cornell University G Boire, MD, FRCPC, Rheumatology Division, Universite de Sherbrooke C A Hitchon, MD, FRCPC, Arthritis Centre
    J Rheumatol 42:46-54. 2015
  9. doi request reprint Prognosis of seronegative patients in a large prospective cohort of patients with early inflammatory arthritis
    Lillian Barra
    From the Department of Medicine, Division of Rheumatology, St Joseph s Health Care London, University of Western Ontario, London Rebecca McDonald Center for Arthritis and Autoimmune Disease, Mount Sinai Hospital, University of Toronto, Toronto Southlake Regional Health Centre, Newmarket, Ontario Rheumatology Division, Universite de Sherbrooke, Sherbrooke Rheumatic Disease Unit, Institut de Rheumatologie, Universite de Montreal, Montreal, Quebec Arthritis Center, University of Manitoba, Winnipeg, Manitoba, Canada Inflammatory Arthritis Center, Hospital for Special Surgery, Department of Biostatistics, Harvard University, Boston, Massachusetts Weill Cornell Medical College, Cornell University, New York, New York, USA Dr Barra has received honoraria from Hoffmann La Roche Ltd, Amgen Canada Inc, AbbVie, further support was provided by Hoffmann La Roche Ltd, UCB Canada Inc, Bristol Myers Squibb Canada Co, Abbott Laboratories Ltd, and Janssen Biotech Inc a wholly owned subsidiary of Johnson and Johnson Inc L Barra, MD, MPH J E Pope, MD, MPH, Department of Medicine, Division of Rheumatology,
    J Rheumatol 41:2361-9. 2014
  10. doi request reprint Determining best practices in early rheumatoid arthritis by comparing differences in treatment at sites in the Canadian Early Arthritis Cohort
    Jamie A Harris
    From the Rheumatology Centre, St Joseph s Health Care, London, Ontario, Canada the Hospital for Special Surgery, New York, New York, USA the Arthritis Centre, University of Manitoba, Winnipeg, Manitoba the University of Toronto, Toronto Southlake Regional Health Centre, Newmarket, Ontario the Faculty of Medicine and Health Sciences, Division of Rheumatology, Universite de Sherbrooke, Sherbrooke, Quebec the Rheumatic Disease Unit, Institut de Rhumatologie, Montreal, Quebec McMaster University, Hamilton, Ontario and Western University, London, Ontario, Canada
    J Rheumatol 40:1823-30. 2013

Collaborators

Detail Information

Publications10

  1. doi request reprint Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice
    Vivian P Bykerk
    Inflammatory Arthritis Center, Hospital for Special Surgery, 535 East 70th Street, New York, NY, 10021, USA
    Clin Rheumatol 34:563-71. 2015
    ..Tocilizumab had a comparable safety profile, and was similarly effective, when used as monotherapy or in combination with DMARDs in a broad population of patients with rheumatoid arthritis...
  2. ncbi request reprint Achieving remission in clinical practice: lessons from clinical trial data
    Vivian P Bykerk
    Hospital for Special Surgery, New York City, USA
    Clin Exp Rheumatol 31:621-32. 2013
    ....
  3. doi request reprint Treatment strategies for early rheumatoid arthritis
    Vivian P Bykerk
    1st Department of Medicine, Hospital for Special Surgery, Weill Cornell Medical College, New York, New York, USA
    Curr Opin Rheumatol 25:375-83. 2013
    ..In this article, we will review recent progress in the development of strategies to enhance outcomes in patients with early RA (ERA)...
  4. pmc Tocilizumab in patients with active rheumatoid arthritis and inadequate responses to DMARDs and/or TNF inhibitors: a large, open-label study close to clinical practice
    Vivian P Bykerk
    Inflammatory Arthritis Center, Hospital for Special Surgery, New York, NY 10021, USA
    Ann Rheum Dis 71:1950-4. 2012
    ....
  5. doi request reprint The new ACR/EULAR remission criteria: rationale for developing new criteria for remission
    Vivian P Bykerk
    Inflammatory Arthritis Center, Hospital for Special Surgery, 535 East 70th Street, 6th Floor, New York, NY 10021, USA
    Rheumatology (Oxford) 51:vi16-20. 2012
    ..Several issues require further study, including the role of imaging, fatigue and the impact of the involvement of joints other than the 28 counted in the ACR/EULAR criteria...
  6. doi request reprint The new ACR/EULAR classification criteria for RA: how are the new criteria performing in the clinic?
    Vivian P Bykerk
    Inflammatory Arthritis Center, Hospital for Special Surgery, 535 East 70th Street, 6th Floor, New York, NY 10021, USA
    Rheumatology (Oxford) 51:vi10-5. 2012
    ..US may be of value in the future, but its role remains to be validated...
  7. doi request reprint Effect of age at menopause on disease presentation in early rheumatoid arthritis: results from the canadian early arthritis cohort
    Lauren E Wong
    Hospital for Special Surgery Weill Cornell Medical College, New York, New York
    Arthritis Care Res (Hoboken) 67:616-23. 2015
    ..Studies suggest that hormonal states affect disease characteristics in women with rheumatoid arthritis (RA). This study investigated how age at menopause affects disease in women presenting with early RA...
  8. doi request reprint Does socioeconomic status affect outcomes in early inflammatory arthritis? Data from a canadian multisite suspected rheumatoid arthritis inception cohort
    Grace Yang
    From the Schulich School of Medicine and Dentistry, Department of Internal Medicine, University of Western Ontario, London, Ontario, Canada Rheumatology, Hospital for Special Surgery, Cornell University, New York, New York, USA Rheumatology Division, Universite de Sherbrooke, Sherbrooke, Quebec Arthritis Centre, University of Manitoba, Winnipeg, Manitoba Southlake Regional Health Centre, Newmarket, Ontario Rheumatic Disease Unit, Institut de Rhumatologie, Montreal, Quebec Rheumatology, Mount Sinai Hospital, University of Toronto, Toronto Rheumatology, St Joseph s Health Care, London, Ontario, Canada G Yang, MD, Schulich School of Medicine and Dentistry, Department of Internal Medicine, University of Western Ontario V P Bykerk, MD, FRCPC, Rheumatology, Hospital for Special Surgery, Cornell University G Boire, MD, FRCPC, Rheumatology Division, Universite de Sherbrooke C A Hitchon, MD, FRCPC, Arthritis Centre
    J Rheumatol 42:46-54. 2015
    ..To assess the effect of socioeconomic status (SES) on outcomes in patients with early inflammatory arthritis, using data from the Canadian Early Arthritis Cohort (CATCH) study...
  9. doi request reprint Prognosis of seronegative patients in a large prospective cohort of patients with early inflammatory arthritis
    Lillian Barra
    From the Department of Medicine, Division of Rheumatology, St Joseph s Health Care London, University of Western Ontario, London Rebecca McDonald Center for Arthritis and Autoimmune Disease, Mount Sinai Hospital, University of Toronto, Toronto Southlake Regional Health Centre, Newmarket, Ontario Rheumatology Division, Universite de Sherbrooke, Sherbrooke Rheumatic Disease Unit, Institut de Rheumatologie, Universite de Montreal, Montreal, Quebec Arthritis Center, University of Manitoba, Winnipeg, Manitoba, Canada Inflammatory Arthritis Center, Hospital for Special Surgery, Department of Biostatistics, Harvard University, Boston, Massachusetts Weill Cornell Medical College, Cornell University, New York, New York, USA Dr Barra has received honoraria from Hoffmann La Roche Ltd, Amgen Canada Inc, AbbVie, further support was provided by Hoffmann La Roche Ltd, UCB Canada Inc, Bristol Myers Squibb Canada Co, Abbott Laboratories Ltd, and Janssen Biotech Inc a wholly owned subsidiary of Johnson and Johnson Inc L Barra, MD, MPH J E Pope, MD, MPH, Department of Medicine, Division of Rheumatology,
    J Rheumatol 41:2361-9. 2014
    ..Our study determined the prognosis of baseline ACPA-negative and RF-negative patients...
  10. doi request reprint Determining best practices in early rheumatoid arthritis by comparing differences in treatment at sites in the Canadian Early Arthritis Cohort
    Jamie A Harris
    From the Rheumatology Centre, St Joseph s Health Care, London, Ontario, Canada the Hospital for Special Surgery, New York, New York, USA the Arthritis Centre, University of Manitoba, Winnipeg, Manitoba the University of Toronto, Toronto Southlake Regional Health Centre, Newmarket, Ontario the Faculty of Medicine and Health Sciences, Division of Rheumatology, Universite de Sherbrooke, Sherbrooke, Quebec the Rheumatic Disease Unit, Institut de Rhumatologie, Montreal, Quebec McMaster University, Hamilton, Ontario and Western University, London, Ontario, Canada
    J Rheumatol 40:1823-30. 2013
    ..To determine site variation by comparing outcomes across sites in an early rheumatoid arthritis cohort...